Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation

• Status: Completed
• Trial end date: 2002-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Bone is lost rapidly and fractures occur in 10-20% of patients who receive organ transplants within 2 years. The purpose of this study is to evaluate long-term effects of a pamidronate-vitamin D-calcium regimen on bone loss, fractures, and safety in recipients of kidney and heart transplants.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Providence Health & Services
• Collaborators: Ochsner Health System; The Heart Institute of Spokane; University of Washington
• Treatments: Calcium; Calcium Carbonate; Calcium, Dietary; Ergocalciferols; Pamidronate; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Kidney or heart transplant recipients

Exclusion Criteria:

• Hyperparathyroidism